Real-world Lyme disease testing results using modified vs standard two-tier test protocols
- PMID: 40587524
- PMCID: PMC12208425
- DOI: 10.1371/journal.pone.0327376
Real-world Lyme disease testing results using modified vs standard two-tier test protocols
Abstract
The modified two-tier test (MTTT) and standard two-tier test (STTT) protocols are being used for Lyme disease serology testing in the clinic. We aimed to compare the real-world testing results of MTTT, a recently approved protocol, vs STTT, a mainstay protocol over the past decades. To this end, we obtained results of Lyme disease testing performed in a US national reference laboratory in 2022 and 2023 and constructed a matched cohort with 66,708 individuals tested using MTTT and 66,708 individuals tested using STTT. We found that, compared with STTT, MTTT identified more test positives in adults aged 18 and older and similar number of test positives in the children and adolescents. The odds ratio (95% confidence interval) of testing positive using MTTT vs STTT was 1.88 (1.79-1.98) in adults and 1.09 (0.97-1.23) in non-adults. In addition, more patients tested positive for immunoglobulin M antibody alone or positive for both immunoglobulin M and immunoglobulin G antibodies using MTTT than STTT.
Copyright: © 2025 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: All authors (YL, ZC, CHT, KV, RSJ, and LAB) were employed by Quest Diagnostics during the study.
Figures


Similar articles
-
A novel single-tier serologic test to diagnose all stages of Lyme disease.J Clin Microbiol. 2025 Sep 10;63(9):e0048325. doi: 10.1128/jcm.00483-25. Epub 2025 Aug 20. J Clin Microbiol. 2025. PMID: 40833084 Free PMC article.
-
Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease.J Infect Dis. 2024 Aug 14;230(Supplement_1):S76-S81. doi: 10.1093/infdis/jiae229. J Infect Dis. 2024. PMID: 39140717
-
Comparison of the Serodiagnostic Accuracy Tests for Lyme Disease in Adults and Children: A Network Meta-Analysis.Pathogens. 2025 Aug 6;14(8):784. doi: 10.3390/pathogens14080784. Pathogens. 2025. PMID: 40872294 Free PMC article. Review.
-
Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.J Clin Microbiol. 2024 May 8;62(5):e0013924. doi: 10.1128/jcm.00139-24. Epub 2024 Apr 10. J Clin Microbiol. 2024. PMID: 38597655 Free PMC article.
-
The Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American Research.PLoS One. 2016 Dec 21;11(12):e0168613. doi: 10.1371/journal.pone.0168613. eCollection 2016. PLoS One. 2016. PMID: 28002488 Free PMC article.
References
-
- Lantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis. 2021;72(1):1–8. doi: 10.1093/cid/ciab049 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous